In vitro and in vivo evaluations of a novel pulsed and controlled osmotic pump capsule

References

• Tajane SR, Kholwal BB, Suryawanshi SS, Tarkase KN. Current trends in pulsatile drug delivery systems. Int J Pharm Sci Res 2012;3:358–66
   Google Scholar
• Bussemer T, Otto I, Bodmeier R. Pulsatile drug-delivery systems. Crit Rev Ther Drug Carrier Syst 2001;18:433–58
   PubMed Web of Science ®Google Scholar
• Songa AS, Meka VS, Nali SR, et al. An in vitro and in vivo investigation into the suitability of compression coated tablets of indomethacin for the treatment of rheumatoid arthritis which follow circadian rhythms. Drug Dev Ind Pharm 2013;39:447–56
   PubMed Web of Science ®Google Scholar
• Bakhshaee M, Binns JS, Stevens HNE, Miller CJ. Pulsatile drug delivery to the colon monitored by gamma scintigraphy. Pharm Res 1992;9:F230
   Google Scholar
• Maroni A, Zema L, Loreti G, et al. Film coatings for oral pulsatile release. Int J Pharm [online] 2013. Available from: http://www.sciencedirect.com/science/article/pii/S0378517313002202 [last accessed 15 March 2013]
   Google Scholar
• Maroni A, Del Curto MD, Cerea M, et al. Polymeric coatings for a multiple-unit pulsatile delivery system: preliminary study on free and applied films. Int J Pharm 2013;440:256–63
   PubMedGoogle Scholar
• Ross AC, MacRae RJ, Walther M, Stevens HN. Chronopharmaceutical drug delivery from a pulsatile capsule device based on programmable erosion. J Pharm Pharmacol 2000;52:903–9
   PubMed Web of Science ®Google Scholar
• Barzegar-Jalali M, Adibkia K, Mohammadi G, et al. Propranolol hydrochloride osmotic capsule with controlled onset of release. Drug Deliv 2007;14:461–8
   PubMed Web of Science ®Google Scholar
• Buchholcz G, Kelemen A, Pintye-Hódi K. Modified-release capsules containing sodium riboflavin 5′-phosphate. Drug Dev Ind Pharm 2013. [Epub ahead of print]. doi:10.3109/03639045.2013.841185
   PubMed Web of Science ®Google Scholar
• McNeil ME, Rashid A, Stevens HNE. Drug dispensing device. US Patent5 342 624; 1994
   Google Scholar
• Liu LX, Khang G, Rhee JM, Lee HB. Monolithic osmotic tablet system for nifedipine delivery. J Control Release 2000;67:309–322
   PubMed Web of Science ®Google Scholar
• Theeuwes F. Elementary osmotic pump. J Pharm Sci 1975;64:1987–91
   PubMed Web of Science ®Google Scholar
• Thombre AG, Cardinal JR, DeNoto AR, et al. Asymmetric membrane capsule for osmotic drug delivery I. Development of manufacturing process. J Control Release 1999;57:55–64
   PubMed Web of Science ®Google Scholar
• Herbig SM, Cardinal JR, Korsmeyer RW, Smith KL. Asymmetric membrane tablet coatings for osmotic drug delivery. J Control Release 1995;35:127–36
   Web of Science ®Google Scholar
• Ram CVS. Βeta-blockers in hypertension. Am J Cardiol 2010;106:1819–25
   PubMed Web of Science ®Google Scholar
• Stavropoulou A, Papadkostaki KG, Sanopoulou M. Experimental and theoretical study of the release kinetics of propranolol hydrochloride from PVA matrices. J Control Release 2005;101:313–15
   PubMed Web of Science ®Google Scholar
• Srujan Kumar M, Ayesha Siddiqua S, Thanusha G, et al. Comprehensive review on pulsatile drug delivery system. J Drug Discov Ther 2013;1:15–22
   Google Scholar
• Guan J, Zhou L, Pan Y, et al. A novel gastro-retentive osmotic pump capsule using asymmetric membrane technology: in vitro and in vivo evaluation. Pharm Res 2009;27:105–14
   PubMed Web of Science ®Google Scholar
• Zou H, Jiang X, Kong L, Gao S. Design and gamma-scintigraphic evaluation of a floating and pulsatile drug delivery system based on an impermeable cylinder. Chem Pharm Bull 2007;55:580–5
   PubMed Web of Science ®Google Scholar
• Wang CY, Ho HO, Lin LH, et al. Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects. Int J Pharm 2005;297:89–97
   PubMed Web of Science ®Google Scholar
• Thombre AG, Cardinal JR, DeNoto AR, Gibbes DC. Asymmetric membrane capsules for osmotic drug delivery II. In vitro and in vivo drug release performance. J Control Release 1999;57:65–73
   PubMed Web of Science ®Google Scholar
• Gan LC, Hou SX, Bi YQ, et al. Optimized preparation of tanshinones A-loaded nanoparticles by central composite design and response surface method. Chi Pharm J 2007;42:758–61
   Google Scholar
• Wagner KM. Like dissolves like. The 19th Biennial Conference on Chemical Education. Purdue University, West Lafayette; 2006
   Google Scholar
• Philip AK, Pathak K, Shakya P. Asymmetric membrane in membrane capsules: a means for achieving delayed and osmotic flow of cefadroxil. Eur J Pharm Biopharm 2008;69:658–66
   PubMed Web of Science ®Google Scholar
• Li XG, Kresse I, Xu ZK, et al. Effect of temperature and pressure on gas transport in ethyl cellulose membrane. Polymer 2001;42:6801–10
   Web of Science ®Google Scholar
• Vidmar V, Jalsenjak I, Kondo T. Volume of water-filled pores in the ethyl cellulose membrane and the permeability of microcapsules. J Pharm Pharmacol 1982;34:411–14
   PubMed Web of Science ®Google Scholar
• Hyppölä R, Husson I, Sundholm F. Evaluation of physical properties of plasticized ethyl cellulose films cast from ethanol solution Part I. Int J Pharm 1996;133:161–70
   Web of Science ®Google Scholar
• Benita S, Donbrow M. Release kinetics of sparingly soluble drugs from ethyl cellulose-walled microcapsules: theophylline microcapsules. J Pharm Pharmacol 1982;34:77–82
   PubMed Web of Science ®Google Scholar
• Rekhi GS, Jambhekar SS. Ethylcellulose -- a polymer review. Drug Dev Ind Pharm 1995;21:61–77
   Web of Science ®Google Scholar
• Lu EX, Jiang ZQ, Zhang QZ, Jiang XG. A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic suspending and expanding agent. J Control Release 2003;92:375–82
   PubMed Web of Science ®Google Scholar
• Tetsuya O, Hiroshi Y, Yoshio K. Control of medicine release from solid dispersion composed of the poly (ethylene oxide)-carboxyvinylpolymer interpolymer complex by varying molecular weight of poly (ethylene oxide). J Control Release 1999;58:87–95
   PubMed Web of Science ®Google Scholar
• Ma L, Deng L, Chen J. Applications of poly(ethylene oxide) in controlled release tablet systems: a review. Drug Dev Ind Pharm 2013. [Epub ahead of print]
   Web of Science ®Google Scholar
• Fauzee AFB, Khamanga SM, Walker RB. The impact of manufacturing variables on in vitro release of clobetasol 17-propionate from pilot scale cream formulations. Drug Dev Ind Pharm 2013. [Epub ahead of print]. doi:10.3109/03639045.2013.842579
   PubMed Web of Science ®Google Scholar
• Zhang W, Li X, Ye T, et al. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology. Int J Pharm 2013;454:354–66
   PubMed Web of Science ®Google Scholar
• Murtaza G, Shahzad M, Ubaid M. Formulation and optimization of celecoxib-loaded microspheres using response surface methodology. Trop J Pharm Res 2012;11:695–702
   Web of Science ®Google Scholar
• Shahzad Y, Afreen U, Nisar Hussain Shah S, Hussain T. Applying response surface methodology to optimize nimesulide permeation from topical formulation. Pharm Dev Technol 2012;18:1391–8
   PubMed Web of Science ®Google Scholar
• Liu LX, Khang G, Rhee JM, Lee HB. Monolithic osmotic tablet system for nifedipine delivery. J Control Release 2000;67:309–22
   PubMed Web of Science ®Google Scholar
• Kuminek G, Kratz JM, Ribeiro R, et al. Pharmacokinetic study of a carbamazepine nanoemulsion in beagle dogs. Int J Pharm 2009;378:146–8
   PubMed Web of Science ®Google Scholar
• Lindeblad MO, Bauer KS, Zakharov AD, et al. Pharmacokinetic and tissue distribution study of [14C]fluasterone in male Beagle dogs following intravenous, oral and subcutaneous dosing routes. Chem Biol Interact 2010;183:317–26
   PubMed Web of Science ®Google Scholar
• Ye X, Tang M, Liu J, et al. Development and validation of a UPLC-MS/MS method for quantification of SKLB010, an investigational anti-inflammatory compound, and its application to pharmacokinetic studies in beagle dogs. J Pharm Biomed Anal 2011;56:366–72
   PubMed Web of Science ®Google Scholar
• Busch U, Schmid J, Heinzel G, et al. Pharmacokinetics of meloxicam in animals and the relevance to humans. Drug Metab Dispos 1998;26:576–84
   PubMed Web of Science ®Google Scholar
• Kang BK, Lee JS, Chon SK, et al. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 2004;274:65–73
   PubMed Web of Science ®Google Scholar
• Venkatesh G, Lai J, Vyas N H, et al. QD Diffucaps drug delivery systems for weakly basic pharmaceutical actives. Birmingham (AL): Aptalis Pharmaceutical Technologies; 2010
   Google Scholar